Thalidomide as Treatment of Lip’s Pyogenic Granuloma
Pyogenic granuloma (PG) is a benign vascular tumor that can be challenging to treat, particularly in aesthetically sensitive areas. We report a case of a 32-year-old man with a PG on the upper lip that did not respond to conventional treatments, including glucocorticoid injections and long-pulse 1064 nm laser therapy. Due to aesthetic concerns and the lack of response to these treatments, the patient was administered oral thalidomide at a nightly dose of 75 mg for 5 months, which resulted in complete regression without recurrence over a 3-year follow-up. This case suggests thalidomide's potential as an effective alternative treatment for PG in sensitive areas.
Authors
- Duan De-jian
- Dan Huang (ORCID: https://orcid.org/0000-0001-6125-1071)
- Jing Nie (ORCID: https://orcid.org/0000-0002-2649-2758)
- Luyao Lai
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Shenzhen Bao'an District People's Hospital (CN)
- Shenzhen Pingle Orthopedic Hospital (CN)
Publication Details
- Journal
- International Medical Case Reports Journal
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/imcrj.s511053
- Primary Topic
- Autoimmune and Inflammatory Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00